The Effect of Adding Transcranial Direct Current Stimulation to Hyperbaric Oxygen Therapy in Patients With Delayed Encephalopathy After Carbon Monoxide Poisoning: A Randomised Controlled Trial

Huifang Cao; Xiaona Tan; Zibo Liu; Long Zhao; Lin Chi; Manyu Li; Chunhui Liu; Hongling Li

doi:10.3389/fneur.2021.719765

The Effect of Adding Transcranial Direct Current Stimulation to Hyperbaric Oxygen Therapy in Patients With Delayed Encephalopathy After Carbon Monoxide Poisoning: A Randomised Controlled Trial

Front Neurol. 2021 Dec 1:12:719765. doi: 10.3389/fneur.2021.719765. eCollection 2021.

Authors

Huifang Cao¹, Xiaona Tan², Zibo Liu³, Long Zhao¹, Lin Chi¹, Manyu Li¹, Chunhui Liu¹, Hongling Li¹

Affiliations

¹ The Department of Rehabilitation, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
² Department of Neurological Rehabilitation, Hebei Medical University Affiliated Children's Hospital of Hebei Province, Shijiazhuang, China.
³ The Department of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.

Abstract

Objective: To investigate the effect of transcranial direct current stimulation (tDCS) combined with hyperbaric oxygen therapy (HBOT) in patients with delayed encephalopathy after carbon monoxide poisoning (DEACMP). Design: A parallel-group, open-label randomised controlled study. Setting: Hyperbaric Oxygen Therapy Room of the Second Hospital of Hebei Medical University. Subjects: A total of 40 patients were recruited for the current study. Patients were randomly divided into a treatment group and a control group (20 cases/group). Interventions: Control group: conventional, individualised rehabilitation therapy. Treatment group: conventional, individualised rehabilitation therapy and tDCS. Main Measures: cognitive function of patients, the Barthel Index (BI). Results: After treatment, significantly higher MMSE and BI scores, as well as a greater reduction in P300 latency and an increase in P300 amplitude, were observed in the treatment group compared to the control group (MMSE: 13 ± 7 vs. 9 ± 5; P300 latency: 342 ± 29 vs. 363 ± 17 ms; P300 amplitude: 7.0 ± 3.3 vs. 5.1 ± 2.7 μV; all P < 0.05). In both groups, however, MMSE and BI scores, in addition to P300 amplitude, were significantly improved; in contrast, there was a decrease in P300 latency in both groups after treatment compared to before treatment (all P < 0.05). Conclusion: Combined with HBOT, tDCS can help improve cognitive function and ADL in patients with DEACMP. This combination therapy might be a helpful method to enhance the recovery of patients with DEACMP.

Keywords: activities of daily living; cognitive function; delayed encephalopathy after carbon monoxide poisoning; hyperbaric oxygen; transcranial direct current stimulation.